Literature DB >> 23959852

Compartmental models for apical efflux by P-glycoprotein: part 2--a theoretical study on transporter kinetic parameters.

Ken Korzekwa, Swati Nagar.   

Abstract

PURPOSE: The impact of efflux transporters in intracellular concentrations of a drug can be predicted with modeling techniques. In Part 1, several compartmental models were developed and evaluated. The goal of Part 2 was to apply these models to the characterization and interpretation of saturation kinetic data.
METHODS: The compartmental models from Part 1 were used to evaluate a previously published dataset from cell lines expressing varying levels of P-glycoprotein. Kinetic parameters for the transporter were estimated and compared across models.
RESULTS: Fits and errors for all compartmental models were identical. All compartmental models predicted more consistent parameters than the Michaelis-Menten model. The 5-compartment model with efflux out of the membrane predicted differential impact of P-gp upon apical versus basolateral drug exposure. Finally, the saturable kinetics of active efflux along with a permeability barrier was modeled to delineate a relationship between intracellular concentration with or without active efflux versus donor concentration. This relationship was not a rectangular hyperbola, but instead was shown to be a quadratic function.
CONCLUSIONS: One approach to estimate an in vivo transporter effect is to first model an intracellular Km value from in vitro data, and use this value along with the appropriate tissue transporter expression levels and relative surface area to calculate the relevant apparent Km (or Ki) values. Together with the results from Part 1, these studies suggest that compartmental models can provide a path forward to better utilize in vitro transporter data for in vivo predictions such as physiologically based pharmacokinetic modeling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23959852      PMCID: PMC3930629          DOI: 10.1007/s11095-013-1163-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition.

Authors:  J Cory Kalvass; Gary M Pollack
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

2.  Decrease in intracellular concentration causes the shift in Km value of efflux pump substrates.

Authors:  Timo Korjamo; Heidi Kemiläinen; Aki T Heikkinen; Jukka Mönkkönen
Journal:  Drug Metab Dispos       Date:  2007-06-04       Impact factor: 3.922

Review 3.  P-glycoprotein and multidrug resistance.

Authors:  M M Gottesman; I Pastan; S V Ambudkar
Journal:  Curr Opin Genet Dev       Date:  1996-10       Impact factor: 5.578

Review 4.  Genetic analysis of the multidrug transporter.

Authors:  M M Gottesman; C A Hrycyna; P V Schoenlein; U A Germann; I Pastan
Journal:  Annu Rev Genet       Date:  1995       Impact factor: 16.830

5.  The steady-state Michaelis-Menten analysis of P-glycoprotein mediated transport through a confluent cell monolayer cannot predict the correct Michaelis constant Km.

Authors:  Joe Bentz; Thuy Thanh Tran; Joseph W Polli; Andrew Ayrton; Harma Ellens
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 6.  A primer on the mechanics of P-glycoprotein the multidrug transporter.

Authors:  M Hennessy; J P Spiers
Journal:  Pharmacol Res       Date:  2006-10-20       Impact factor: 7.658

7.  Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.

Authors:  Yoshiyuki Shirasaka; Yoshie Masaoka; Makoto Kataoka; Shinji Sakuma; Shinji Yamashita
Journal:  Drug Metab Dispos       Date:  2008-02-14       Impact factor: 3.922

8.  Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells.

Authors:  Poulomi Acharya; Michael P O'Connor; Joseph W Polli; Andrew Ayrton; Harma Ellens; Joe Bentz
Journal:  Drug Metab Dispos       Date:  2007-10-29       Impact factor: 3.922

9.  Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery.

Authors:  Tian-Meng Sun; Jin-Zhi Du; Li-Feng Yan; Hai-Quan Mao; Jun Wang
Journal:  Biomaterials       Date:  2008-08-19       Impact factor: 12.479

10.  Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans.

Authors:  Takao Watanabe; Hiroyuki Kusuhara; Kazuya Maeda; Yoshihisa Shitara; Yuichi Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  2008-11-10       Impact factor: 4.030

View more
  8 in total

Review 1.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  AAPS J       Date:  2016-06-30       Impact factor: 4.009

2.  Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

Authors:  Priyanka R Kulkarni; Amir S Youssef; Aneesh A Argikar
Journal:  Methods Mol Biol       Date:  2021

3.  Drug Distribution. Part 1. Models to Predict Membrane Partitioning.

Authors:  Swati Nagar; Ken Korzekwa
Journal:  Pharm Res       Date:  2016-12-15       Impact factor: 4.200

4.  Prediction of Tissue-Plasma Partition Coefficients Using Microsomal Partitioning: Incorporation into Physiologically based Pharmacokinetic Models and Steady-State Volume of Distribution Predictions.

Authors:  Kimberly Holt; Min Ye; Swati Nagar; Ken Korzekwa
Journal:  Drug Metab Dispos       Date:  2019-07-19       Impact factor: 3.922

Review 5.  Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.

Authors:  Avner Schlessinger; Matthew A Welch; Herman van Vlijmen; Ken Korzekwa; Peter W Swaan; Pär Matsson
Journal:  Clin Pharmacol Ther       Date:  2018-08-30       Impact factor: 6.875

6.  Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport.

Authors:  Priyanka Kulkarni; Kenneth Korzekwa; Swati Nagar
Journal:  J Pharmacol Exp Ther       Date:  2016-07-22       Impact factor: 4.030

7.  Using partition analysis as a facile method to derive net clearances.

Authors:  Ken Korzekwa; Jaydeep Yadav; Swati Nagar
Journal:  Clin Transl Sci       Date:  2022-06-02       Impact factor: 4.438

8.  A permeability- and perfusion-based PBPK model for improved prediction of concentration-time profiles.

Authors:  Ken Korzekwa; Casey Radice; Swati Nagar
Journal:  Clin Transl Sci       Date:  2022-05-31       Impact factor: 4.438

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.